SCIENTIFIC TALK AMD | 11 ottobre 2022 | ore 17 Share Post navigation Metabolomic profiling of the effects of dapagliflozin in heart failure with reduced ejection fraction: DEFINE-HFManagement of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
